Patrick Burnett files SEC Form 4 disclosures for Arcutis Biotherapeutics, Inc.. They have made 21 open-market trades across 1 company since 2022, most recently 2026-08-19.
CIK 0001741987
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 21 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ARQT | 117,592 | $3.4M |
Shares reported on the most recent Form 4, priced at the 2026-08-21 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ARQT | SELL | 2026-08-19 | 2026-08-21 | $27.00 | $46K | -3.0% | +5.7% | — |
| ARQT | SELL | 2026-08-11 | 2026-08-13 | $26.33 | $395K | -2.4% | -4.6% | — |
| ARQT | SELL | 2026-08-03 | 2026-08-05 | $26.12 | $25K | -11.8% | -17.7% | — |
| ARQT | SELL | 2026-05-11 | 2026-05-13 | $21.05 | $5K | -4.1% | +10.7% | +19.0% |
| ARQT | SELL | 2026-05-04 | 2026-05-06 | $23.61 | $16K | -12.4% | -7.2% | +13.8% |
| ARQT | SELL | 2026-03-02 | 2026-03-03 | $25.18 | $158K | -3.0% | +0.8% | -8.3% |
| ARQT | SELL | 2026-02-02 | 2026-02-04 | $25.72 | $346K | +1.6% | -8.3% | -10.5% |
| ARQT | SELL · 10b5-1 | 2026-01-05 | 2026-01-07 | $28.98 | $72K | -11.3% | -6.4% | -20.2% |
| ARQT | SELL | 2025-12-31 | 2026-01-02 | $29.20 | $50K | -7.9% | -11.9% | -18.6% |
| ARQT | SELL · 10b5-1 | 2025-12-15 | 2025-12-17 | $28.94 | $333K | -1.6% | -9.4% | -20.4% |
| ARQT | SELL · 10b5-1 | 2025-11-06 | 2025-11-10 | $24.18 | $417K | +15.7% | +26.0% | +13.8% |
| ARQT | SELL · 10b5-1 | 2025-11-03 | 2025-11-05 | $24.12 | $313K | +9.4% | +30.4% | +9.4% |
| ARQT | SELL · 10b5-1 | 2025-08-19 | 2025-08-21 | $15.82 | $66K | +2.8% | +12.1% | +79.9% |
| ARQT | SELL · 10b5-1 | 2025-08-08 | 2025-08-12 | $14.03 | $108K | +6.8% | +18.2% | +58.7% |
| ARQT | SELL | 2025-08-04 | 2025-08-05 | $14.33 | $38K | +12.2% | +7.7% | +64.5% |
| ARQT | SELL · 10b5-1 | 2025-07-10 | 2025-07-14 | $15.06 | $519K | -5.8% | -2.0% | +29.9% |
| ARQT | SELL · 10b5-1 | 2025-05-08 | 2025-05-09 | $13.59 | $105K | +1.9% | +5.2% | +4.5% |
| ARQT | SELL | 2025-05-02 | 2025-05-05 | $15.19 | $39K | -9.0% | -11.4% | -3.0% |
| ARQT | SELL · 10b5-1 | 2025-03-13 | 2025-03-17 | $14.99 | $1.8M | -0.9% | -20.2% | -17.5% |
| ARQT | SELL | 2025-03-03 | 2025-03-04 | $13.09 | $49K | +9.5% | +21.0% | +1.0% |
| ARQT | SELL | 2025-02-03 | 2025-02-04 | $12.70 | $308K | -2.7% | +10.4% | +17.4% |
| ARQT | SELL | 2024-12-31 | 2024-12-31 | $14.00 | $24K | -6.5% | -3.7% | +10.1% |
| ARQT | SELL | 2024-11-22 | 2024-11-26 | $10.14 | $325K | +8.4% | +28.7% | +6.8% |
| ARQT | SELL | 2024-11-14 | 2024-11-18 | $10.29 | $1.4M | +39.8% | +43.6% | +34.1% |
| ARQT | SELL | 2024-11-04 | 2024-11-05 | $8.68 | $268K | -1.2% | +31.4% | +35.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.